Outcomes may improve with disease-modifying drugs and lifestyle change if Alzheimer's could be identified earlier.

Rippl, a Seattle startup providing virtual health care for patients with dementia, announced $23 million in new funding.

The five-year journey Ed Mezzanotte and his wife, Lorraine, traveled before she died from Alzheimer’s was marked by heartache ...

Researchers show that a pill form of the drug dronabinol, an FDA-approved synthetic version of marijuana's main ingredient, THC, reduces agitation in patients with Alzheimer's by an average of 30%.

Anxiety and depression are significant risk factors for AD, and conversely, AD increases the likelihood of developing these psychiatric conditions. A systematic review of 14,760 studies showed ...

Rippl, a virtual dementia care company, secured $23 million in series A funding to expand its services to patients in more ...

A daughter chooses to care for her mother with Alzheimer's, defying societal expectations and finding growth and connection ...

A synthetic form of the active ingredient in cannabis helps reduce agitation in people with Alzheimer's, new research ...

Emory University will investigate the role Alzheimer’s special care units play in reducing racial and ethnic disparities in ...

Federal initiative provides a break for families caring for loved ones with Alzheimer's or dementia, with Medicare covering ...

An FDA-approved synthetic version of THC (the main ingredient in cannabis) reduces agitation in patients with Alzheimer's ...

Through the work of the charitable organization Hilarity for Charity, Lauren Miller Rogen envisions a world where senior ...